Idarubicin [idarubicin]
topical
19
- Terms
-
4-Demethoxydaunorubicin
4-Desmethoxydaunorubicin
Idarubicin Hydrochloride
IMI-30
NSC-256439
Persistent link
https://www.medvik.cz/link/D015255
Definition
An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA.
- DUI
- D015255 MeSH Browser
- CUI
- M0023493
- CAS
- 5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-
- Previous indexing
- Antibiotics, Antineoplastic (1967-1988); Daunorubicin/analogs & derivatives (1975-1988)
- History note
- 89
- Public note
- 89
Allowable subheadings
- AD
- administration & dosage 10
- AE
- adverse effects 4
- AG
- agonists 1
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 1
- PK
- pharmacokinetics 1
- PD
- pharmacology 5
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 9
- TO
- toxicity 1
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.455.426.559.847.562.050.200.150
Carubicin
D02.455.426.559.847.562.050.200.650
Nogalamycin
D04.615.562.050.200.150
Carubicin
D04.615.562.050.200.650
Nogalamycin
D09.408.051.059.200.150
Carubicin
D09.408.051.059.200.650
Nogalamycin